Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Algernon Pharmaceuticals Inc. C.AGN

Alternate Symbol(s):  AGNPF

Algernon Pharmaceuticals Inc. is a clinical-stage drug development company. The Company is focused on developing repurposed therapeutic drugs in the areas of non-alcoholic steatohepatitis (NASH), a type of liver disease, chronic kidney disease (CKD), inflammatory bowel disease (IBD), idiopathic pulmonary fibrosis (IPF) and chronic cough as well as advancing a stroke program using N, N-Dimethyltryptamine (DMT). The Company operates through two segments, which includes the development of repurposed therapeutic drugs in Canada and the facilitation of the Company’s lead drug candidates into off-label phase II clinical trials (humans) in Australia. The Company's pipeline includes NP-251 (Repirinast) and AP-188 (DMT). The Company, through its subsidiary, Algernon NeuroScience Inc., is developing AP-188 (DMT) as a potential treatment for stroke and traumatic brain injury (TBI) recovery. Its NP-251 is being developed as a potential treatment for kidney inflammation and fibrosis.


CSE:AGN - Post by User

Comment by 294everon May 06, 2020 12:35am
269 Views
Post# 30991248

RE:RE:Has anyone considered??

RE:RE:Has anyone considered??

Yes I see May 12

point was really that I'm fairly certain there is a lot of interest in AGN and the people that can bring the money to this PP have probably somehow negotiated a bigger/better position for themselves. Wouldn't we all if we could?

I'm trying to think logically here because as 
i think someone even pointed out in an earlier post that a lower share price takes money out of managements pocket. These guys aren't exactly rolling in it with salaries yet. I'm sure this wasn't some premeditated swindle. They are trying to be transparent and keeping us abreast of information as it comes so we can make a better educated decision to buy/sell. 

I have 100% faith what management team is doing is with integrity and in the best interest of the company at this point. What reason do we have to believe otherwise?
The data, results and feedback all excellent.

Lets keep calm and Algernon!

Although not gonna lie as I will agree with everyone these halts are a bit of a pain in the ball$

best of luck to all!

Bullboard Posts